SCHEMBL4153586

SCHEMBL4153586

Cc1cccc(/C=C2\c3ccccc3CCc3cc(Cl)ccc32)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.49
PGR P06401 1/20 0.49
NR3C2 P08235 1/20 0.49
AR P10275 1/20 0.49
CYP19A1 P11511 4/20 0.42
CYP11B1 P15538 4/20 0.42
CYP11B2 P19099 4/20 0.42
MAOB P27338 3/20 0.41
MAOA P21397 2/20 0.41
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HCRTR1 O43613 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HRH1 P35367 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4153587 1.00 NR3C1 (0.49) NR3C1PGRNR3C2ARCYP19A1
SCHEMBL4155418 0.89 AR (0.58) NR3C1PGRNR3C2ARCYP19A1
SCHEMBL4156051 0.84 MIF (0.55) NR3C1PGRNR3C2ARCYP19A1
SCHEMBL4156234 0.84 NR3C1 (0.46) NR3C1PGRNR3C2ARCYP19A1
SCHEMBL8348970 0.84 MIF (0.55) NR3C1PGRNR3C2ARCYP19A1
SCHEMBL4156231 0.84 NR3C1 (0.46) NR3C1PGRNR3C2ARCYP19A1
SCHEMBL4156050 0.84 MIF (0.55) NR3C1PGRNR3C2ARCYP19A1
SCHEMBL8349673 0.83 CYP19A1 (0.38) NR3C1PGRNR3C2ARCYP19A1
SCHEMBL13814233 0.82 CYP19A1 (0.41) CYP19A1CYP11B1CYP11B2MAOBMAOA
SCHEMBL13802622 0.81 AR (0.46) NR3C1PGRNR3C2ARCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149445-A1 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS COGHLAN MICHAEL JOSEPH 2009-06-11 US disclosed
US-7411072-B2 Tricyclic steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2008-08-12 US disclosed
US-20060063759-A1 Tricyclic steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149445-A1 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS NR5A1, NR3C2, NR3C1 NR3C1 3/4885PGR 54/4885NR3C2 2/4885
US-20060063759-A1 Tricyclic steroid hormone nuclear receptor modulators NR5A1, NR3C2, NR3C1 NR3C1 3/4885PGR 50/4885NR3C2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.